484 related articles for article (PubMed ID: 31817678)
1. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
Fabris C; Ozaslan B; Breton MD
Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678
[No Abstract] [Full Text] [Related]
2. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
[TBL] [Abstract][Full Text] [Related]
3. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.
Cappon G; Facchinetti A; Sparacino G; Georgiou P; Herrero P
Sensors (Basel); 2019 Jul; 19(14):. PubMed ID: 31323886
[TBL] [Abstract][Full Text] [Related]
4. Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.
Schiavon M; Dalla Man C; Cobelli C
Diabetes Technol Ther; 2018 Feb; 20(2):98-105. PubMed ID: 29355438
[TBL] [Abstract][Full Text] [Related]
5. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
[TBL] [Abstract][Full Text] [Related]
6. Method for automatic adjustment of an insulin bolus calculator: in silico robustness evaluation under intra-day variability.
Herrero P; Pesl P; Bondia J; Reddy M; Oliver N; Georgiou P; Toumazou C
Comput Methods Programs Biomed; 2015 Apr; 119(1):1-8. PubMed ID: 25733405
[TBL] [Abstract][Full Text] [Related]
7. Recent Exposure to Hypoglycemia Increases Glucose Variability Following a Hyper/Hypoglycemic Metabolic Challenge in T1D.
Fabris C; Farhy LS; Anderson SM; Nass RM; Kovatchev BP; Breton MD
J Diabetes Sci Technol; 2018 Mar; 12(2):311-317. PubMed ID: 28942668
[TBL] [Abstract][Full Text] [Related]
8. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.
El Fathi A; Fabris C; Breton MD
Front Endocrinol (Lausanne); 2021; 12():795895. PubMed ID: 35082757
[TBL] [Abstract][Full Text] [Related]
9. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
[TBL] [Abstract][Full Text] [Related]
10. Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments.
Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
IEEE Trans Biomed Eng; 2018 Jun; 65(6):1281-1290. PubMed ID: 28866479
[TBL] [Abstract][Full Text] [Related]
11. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D.
Brown SA; Jiang B; McElwee-Malloy M; Wakeman C; Breton MD
J Diabetes Sci Technol; 2015 Oct; 9(6):1192-9. PubMed ID: 26468135
[TBL] [Abstract][Full Text] [Related]
12. Reliability of Inpatient CGM: Comparison to Standard of Care.
Price C; Ditton G; Russell GB; Aloi J
J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
[TBL] [Abstract][Full Text] [Related]
13. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
[No Abstract] [Full Text] [Related]
14. Safety and Feasibility Evaluation of Step Count Informed Meal Boluses in Type 1 Diabetes: A Pilot Study.
Ozaslan B; Brown SA; Pinnata J; Barnett CL; Carr K; Wakeman CA; Clancy-Oliveri M; Breton MD
J Diabetes Sci Technol; 2022 May; 16(3):670-676. PubMed ID: 33794675
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
[TBL] [Abstract][Full Text] [Related]
16. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
Pettus J; Edelman SV
J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
[TBL] [Abstract][Full Text] [Related]
17. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
18. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Pettus J; Edelman SV
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
[TBL] [Abstract][Full Text] [Related]
19. Performance Effect of Adjusting Insulin Sensitivity for Model-Based Automated Insulin Delivery Systems.
Moscoso-Vasquez M; Fabris C; Breton MD
J Diabetes Sci Technol; 2023 Nov; 17(6):1470-1481. PubMed ID: 37864340
[TBL] [Abstract][Full Text] [Related]
20. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
